Quick Answer
VYCOR MEDICAL INC reported Revenue (ASC 606) of $1.86 million for fiscal year 2025.
VYCOR MEDICAL INC Revenue (ASC 606) — Annual History
| Fiscal Year | Revenue (ASC 606) | YoY Change |
|---|---|---|
| 2025 | $1.86M | +17.2% |
| 2024 | $1.59M | +8.8% |
| 2023 | $1.46M | +19.4% |
| 2022 | $1.22M | -12.2% |
| 2021 | $1.39M | +22.0% |
| 2020 | $1.14M | -18.0% |
| 2019 | $1.39M | -7.7% |
| 2018 | $1.51M | +9.0% |
| 2017 | $1.38M | — |
Quarterly Revenue (ASC 606)
| Quarter Ending | Revenue (ASC 606) | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $513.8K | +31.5% | +3.5% |
| June 30, 2025 | $496.4K | +22.2% | +13.7% |
| March 31, 2025 | $436.4K | +29.5% | +11.6% |
| September 30, 2024 | $390.9K | +26.7% | -3.8% |
| June 30, 2024 | $406.3K | -15.8% | +20.6% |
| March 31, 2024 | $337.0K | -6.7% | +9.2% |
| September 30, 2023 | $308.6K | -0.4% | -36.1% |
| June 30, 2023 | $482.8K | +47.2% | +33.7% |
- VYCOR MEDICAL INC showed an increase of +17.2% in Revenue (ASC 606) compared to the prior fiscal year.
- Over the 2017–2025 period, VYCOR MEDICAL INC’s revenue (asc 606) has grown by 34.5% (from $1.38 million to $1.86 million).
- The most recent figure is from VYCOR MEDICAL INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: